Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
L-364,373 | 103342-82-1 | sc-204036 sc-204036B sc-204036C | 2.5 mg 5 mg 10 mg | $240.00 $469.00 $877.00 | ||
L-364,373 functions as a potent KCNQ1 modulator, characterized by its ability to stabilize specific ion channel conformations. Its unique binding affinity is influenced by intricate hydrogen bonding and hydrophobic interactions, which fine-tune channel gating dynamics. The compound's distinct electronic properties facilitate rapid charge transfer, impacting ion flow and channel kinetics. Additionally, L-364,373 demonstrates a high degree of selectivity, allowing for targeted modulation of cellular excitability. | ||||||
GW 3965 hydrochloride | 405911-17-3 | sc-224011 sc-224011A sc-224011B | 5 mg 25 mg 1 g | $137.00 $474.00 $3060.00 | ||
GW3965 indirectly activates KCNQ1 by modulating cholesterol levels. It activates LXR, leading to increased expression of genes involved in cholesterol efflux. This influences membrane lipid composition, potentially impacting KCNQ1 channel activity and promoting repolarization. | ||||||
NS 1643 | 448895-37-2 | sc-204135 sc-204135A | 10 mg 50 mg | $121.00 $464.00 | 3 | |
NS1643 directly activates KCNQ1 by enhancing channel conductance. It stabilizes the open state of KCNQ1 channels, increasing potassium efflux and promoting repolarization in excitable cells, making it a potential pharmacological tool for modulating KCNQ1 channel function. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $31.00 | 3 | |
Niflumic Acid directly activates KCNQ1 by potentiating channel currents. It affects KCNQ1 gating properties, increasing potassium efflux and promoting repolarization in excitable cells. This modulation is crucial for maintaining proper cardiac and neuronal function. | ||||||
Flupirtine Maleate | 75507-68-5 | sc-218512 | 10 mg | $101.00 | 1 | |
Flupirtine directly activates KCNQ1 by potentiating channel currents. It affects KCNQ1 gating properties, increasing potassium efflux and promoting repolarization in excitable cells. This pharmacological agent holds potential in modulating KCNQ1 function in various physiological contexts. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Zinc Pyrithione indirectly activates KCNQ1 by inhibiting the activity of KCNQ1 ubiquitin ligases, preventing KCNQ1 ubiquitination and degradation. This leads to increased KCNQ1 protein levels, enhancing its presence in the cell membrane and promoting ion channel activity. |